Form 3 Filing for Cue Biopharma, Inc. - Initial Statement of Beneficial Ownership

This filing reports on Form 3, an Initial Statement of Beneficial Ownership, for Sumita Ray, identified as a corporate secretary and Chief Legal Compliance Officer of Cue Biopharma, Inc. (CUE). The report details holdings as of June 1, 2026. Ray beneficially owns 54,589 shares of Common Stock directly. Additionally, Ray holds a stock option to purchase 109,179 shares of Common Stock, exercisable at $30.42 per share, with an expiration date of May 1, 2036. This option becomes exercisable in equal quarterly installments over four years, starting from May 1, 2026, as indicated by footnote F1.